#malaria transmission-blocking vaccines are a very promising approach to #endmalaria!
@FinlayInstituto
Newly published research on the expression & characterization of a transmission-blocking malaria vaccine candidate: https://t.co/hRCjvSURLm
RT @ATUM_bio: #Malaria #vaccine candidate Pfs230D1+ is limited by poor yield and glycosyl heterogeneity. @MalariaVaccine @UnivOfKansase @NI…
#Malaria #vaccine candidate Pfs230D1+ is limited by poor yield and glycosyl heterogeneity. @MalariaVaccine @UnivOfKansase @NIH use optimized sequence from @ATUM_bio to increase yield, improve antigen integrity and homogeneity for upcoming clinical trials h
RT @MalariaJournal: The Pfs230 N-terminal fragment, Pfs230D1+: expression and characterization of a potential malaria transmission-blocking…
The Pfs230 N-terminal fragment, Pfs230D1+: expression and characterization of a potential malaria transmission-blocking vaccine candidate https://t.co/pW30EDD598